Jason Gee - Concepedia

Author

Jason Gee

The University of Texas MD Anderson Cancer Center

Also Known As

Angela Hadjipanayis, Gee, Jason R., J. Gee, JASON GEE, JASON R. GEE, Jason Gee, Jason R Gee, Jason R. Gee, Jason Robert Gee

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of Wisconsin–Madison University of Wisconsin Carbone Cancer Center National Cancer Institute University of Rochester Medical Center

About

Jason Gee is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	277
2	Anatomy	1	1	20
3	Anesthesia	1	1	13
4	Cell Biology	1	1	22
5	Cellular Physiology	1	1	22

Jason Gee

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Multimodality Management of Urachal Carcinoma: The M. D. Anderson Cancer Center Experience Arlene O. Siefker‐Radtke, Jason Gee, Yu Shen, The Journal of Urology	2003	301
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index Luc Desnoyers, Olga Vasiljeva, Jennifer Richardson, Science Translational Medicine	2013	261
Micropapillary bladder cancer Ashish M. Kamat, Colin P. Dinney, Jason Gee, Cancer	2007	258
Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies Alan W. Partin, Leander Van Neste, Eric A. Klein, The Journal of Urology	2014	221
The Case for Early Cystectomy in the Treatment of Nonmuscle Invasive Micropapillary Bladder Carcinoma Ashish M. Kamat, Jason Gee, Colin P. Dinney, The Journal of Urology	2006	220
Long‐term outcome of hematuria home screening for bladder cancer in men Edward M. Messing, Ralph Madeb, Terry Young, Cancer	2006	179
A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients Edward M. Messing, Jason Gee, Daniel R. Saltzstein, Cancer Prevention Research UrologyOncologyPlacebo ArmChemoprevention StrategyGenitourinary Cancer	2012	90
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers Jason Gee, Daniel R. Saltzstein, KyungMann Kim, Cancer Prevention Research	2017	64
Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression Stephanie Tseng-Rogenski, Jason Gee, Kathleen Woods Ignatoski, American Journal Of Pathology UrologyOncologyGenitourinary CancerMedicinePathology	2010	54
Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer Jason Gee, I-Ling Lee, David Jendiroba, Oncology Reports	2006	51

Page 1